Synthetic Biology Market Players:
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck KGaA
- Agilent Technologies Inc.
- Danaher Corporation
- GenScript Biotech Corporation
- Twist Bioscience Corporation
- Amyris, Inc.
- Intrexon Corporation
- Synthetic Genomics Inc.
- Codexis, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of synthetic biology is estimated at USD 22.67 billion.
The global synthetic biology market size crossed USD 18.87 billion in 2025 and is likely to expand at a CAGR of around 22.4%, surpassing USD 142.42 billion revenue by 2035.
North America synthetic biology market will hold over 35% share by 2035, growing genome-editing treatments and insurance coverage.
Key players in the market include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Danaher Corporation, GenScript Biotech Corporation, Twist Bioscience Corporation, Amyris, Inc., Intrexon Corporation, Synthetic Genomics Inc., Codexis, Inc.
